356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s Disease

Ellen Bradley, D Parker Kelley, Martin Picard, Balazs Szigeti, Kimberly Sakai, Gisele Fernandes, Jill Ostrem, Caroline Tanner, Patrick Finley, Connie Ludwig, Katiah Llerena, Zach Busby, Amber McKernan, Jose Rafael Zuzuarregui, Meredith Bock, Aliss Wang, Andrew Penn, Josh Woolley, Aoife O'Donovan

Biological Psychiatry • April 25, 2026 Peer reviewed • DOI: 10.1016/j.biopsych.2026.03.590 • via OpenAlex